RxDoctor Payments Data

Ryan McEnaney, MD

Vascular Surgery · Saint Louis, MONPI 1992908354

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 49.4% of the total. 2025 is the largest year on record at $918, 9.7 times the $95 reported in 2019. That places this record below the midpoint for vascular surgery clinicians in MO, where the typical reported total is $6,319.

$1,264in general payments, 2019–2025

Across 21 payments — averaging $60.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$624
  • Boston Scientific$230
  • Ossur Americas, Inc.$149
  • Shockwave Medical, Inc$127
  • Cook Medical LLC$109
  • Medtronic$26

What the payments were for

  • Food & beverage$1,264100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
W. L. Gore & Associates, Inc.10$624
Boston Scientific4$230
Ossur Americas, Inc.2$149
Shockwave Medical, Inc1$127
Cook Medical LLC3$109
Medtronic1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,264 in reported general payments places this provider in the 20th percentile of 92 vascular surgery providers in Missouri.

See all vascular surgery providers in Missouri →

Medicare billing

Part B allowed, 2024
$65,171
Medicare patients
370
Services billed
536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium13$121
ClopidogrelClopidogrel Bisulfate12$96

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →